AT-9010 (2'-methyl-2'-fluoro guanosine triphosphate) is a GTP analog whose prodrug, AT-752 is under consideration in human medicine as a potential antiviral drug against certain flaviviruses. It was previously believed to inhibit viral replication by acting primarily as a chain terminator. However, it was discovered recently that it also binds the GTP binding site of the methyltransferase (MTase) domain of the orthoflavivirus polymerase, thus interfering with RNA capping. Here, we investigated the binding of AT-9010 to Ntaya and Zika virus MTases. Structural analysis using X-ray crystallography revealed similar interactions between the base and sugar moieties of AT-9010 and key residues in both MTases, although differences in hydrogen bonding were observed. Our analysis also suggested that the triphosphate part of AT-9010 is flexible. Despite minor variations, the overall binding mode of AT-9010 was found to be the same for all of the flaviviral MTases examined, suggesting a structural basis for the efficacy of AT-9010 against multiple orthoflavivirus MTases.

• MeSH
• antivirové látky * chemie   farmakologie   metabolismus   MeSH
• Flaviviridae * enzymologie   MeSH
• guanosintrifosfát * analogy a deriváty   metabolismus   chemie   MeSH
• krystalografie rentgenová MeSH
• lidé MeSH
• methyltransferasy * metabolismus   chemie   genetika   MeSH
• molekulární modely MeSH
• vazba proteinů MeSH
• vazebná místa MeSH
• virové proteiny * metabolismus   chemie   MeSH
• virus zika * enzymologie   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• antivirové látky * MeSH
• guanosintrifosfát * MeSH
• methyltransferasy * MeSH
• virové proteiny * MeSH

Protein-RNA interactions play important biological roles and hence reactive RNA probes for cross-linking with proteins are important tools in their identification and study. To this end, we designed and synthesized 5'-O-triphosphates bearing a reactive squaramate group attached to position 5 of cytidine or position 7 of 7-deazaadenosine and used them as substrates for polymerase synthesis of modified RNA. In vitro transcription with T7 RNA polymerase or primer extension using TGK polymerase was used for synthesis of squaramate-modified RNA probes which underwent covalent bioconjugations with amine-linked fluorophore and lysine-containing peptides and proteins including several viral RNA polymerases or HIV reverse transcriptase. Inhibition of RNA-depending RNA polymerases from Japanese Encephalitis virus was observed through formation of covalent cross-link which was partially identified by MS/MS analysis. Thus, the squaramate-linked NTP analogs are useful building blocks for the synthesis of reactive RNA probes for bioconjugations with primary amines and cross-linking with lysine residues.

• Publikační typ
• časopisecké články MeSH

We have identified seven putative guanine quadruplexes (G4) in the RNA genome of tick-borne encephalitis virus (TBEV), a flavivirus causing thousands of human infections and numerous deaths every year. The formation of G4s was confirmed by biophysical methods on synthetic oligonucleotides derived from the predicted TBEV sequences. TBEV-5, located at the NS4b/NS5 boundary and conserved among all known flaviviruses, was tested along with its mutated variants for interactions with a panel of known G4 ligands, for the ability to affect RNA synthesis by the flaviviral RNA-dependent RNA polymerase (RdRp) and for effects on TBEV replication fitness in cells. G4-stabilizing TBEV-5 mutations strongly inhibited RdRp RNA synthesis and exhibited substantially reduced replication fitness, different plaque morphology and increased sensitivity to G4-binding ligands in cell-based systems. In contrast, strongly destabilizing TBEV-5 G4 mutations caused rapid reversion to the wild-type genotype. Our results suggest that there is a threshold of stability for G4 sequences in the TBEV genome, with any deviation resulting in either dramatic changes in viral phenotype or a rapid return to this optimal level of G4 stability. The data indicate that G4s are critical elements for efficient TBEV replication and are suitable targets to tackle TBEV infection.

• MeSH
• antivirové látky * farmakologie   terapeutické užití   MeSH
• G-kvadruplexy * MeSH
• klíšťová encefalitida farmakoterapie   genetika   MeSH
• lidé MeSH
• ligandy MeSH
• RNA virová genetika   MeSH
• RNA-dependentní RNA-polymerasa genetika   MeSH
• viry klíšťové encefalitidy * účinky léků   genetika   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• antivirové látky * MeSH
• ligandy MeSH
• RNA virová MeSH
• RNA-dependentní RNA-polymerasa MeSH

Positive-sense single-stranded RNA (+RNA) viruses have proven to be important pathogens that are able to threaten and deeply damage modern societies, as illustrated by the ongoing COVID-19 pandemic. Therefore, compounds active against most or many +RNA viruses are urgently needed. Here, we present PR673, a helquat-like compound that is able to inhibit the replication of SARS-CoV-2 and tick-borne encephalitis virus in cell culture. Using in vitro polymerase assays, we demonstrate that PR673 inhibits RNA synthesis by viral RNA-dependent RNA polymerases (RdRps). Our results illustrate that the development of broad-spectrum non-nucleoside inhibitors of RdRps is feasible.

• Klíčová slova
• Flaviruses, RNA-dependent RNA-polymerase, SARS-CoV-2, antiviral agents, helquat-like compound,
• MeSH
• COVID-19 * MeSH
• lidé MeSH
• pandemie MeSH
• RNA-dependentní RNA-polymerasa MeSH
• SARS-CoV-2 MeSH
• viry klíšťové encefalitidy * MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• RNA-dependentní RNA-polymerasa MeSH

Coronaviral methyltransferases (MTases), nsp10/16 and nsp14, catalyze the last two steps of viral RNA-cap creation that takes place in cytoplasm. This cap is essential for the stability of viral RNA and, most importantly, for the evasion of innate immune system. Non-capped RNA is recognized by innate immunity which leads to its degradation and the activation of antiviral immunity. As a result, both coronaviral MTases are in the center of scientific scrutiny. Recently, X-ray and cryo-EM structures of both enzymes were solved even in complex with other parts of the viral replication complex. High-throughput screening as well as structure-guided inhibitor design have led to the discovery of their potent inhibitors. Here, we critically summarize the tremendous advancement of the coronaviral MTase field since the beginning of COVID pandemic.

• MeSH
• aminokyseliny chemie   MeSH
• Coronavirus účinky léků   enzymologie   genetika   MeSH
• lidé MeSH
• methyltransferasy antagonisté a inhibitory   chemie   metabolismus   MeSH
• metylace MeSH
• molekulární konformace MeSH
• molekulární modely MeSH
• molekulární struktura MeSH
• objevování léků MeSH
• RNA virová chemie   genetika   metabolismus   MeSH
• sekvence aminokyselin MeSH
• vazba proteinů MeSH
• vazebná místa MeSH
• vztahy mezi strukturou a aktivitou MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• aminokyseliny MeSH
• methyltransferasy MeSH
• RNA virová MeSH

SARS-CoV-2 has caused an extensive pandemic of COVID-19 all around the world. Key viral enzymes are suitable molecular targets for the development of new antivirals against SARS-CoV-2 which could represent potential treatments of the corresponding disease. With respect to its essential role in the replication of viral RNA, RNA-dependent RNA polymerase (RdRp) is one of the prime targets. HeE1-2Tyr and related derivatives were originally discovered as inhibitors of the RdRp of flaviviruses. Here, we present that these pyridobenzothiazole derivatives also significantly inhibit SARS-CoV-2 RdRp, as demonstrated using both polymerase- and cell-based antiviral assays.

• Klíčová slova
• COVID-19, RNA-dependent RNA polymerase, SAR-CoV-2, antiviral agents, non-nucleotide inhibitor,
• MeSH
• adenosinmonofosfát analogy a deriváty   farmakologie   MeSH
• alanin analogy a deriváty   farmakologie   MeSH
• antivirové látky farmakologie   MeSH
• benzothiazoly farmakologie   MeSH
• buněčné linie MeSH
• inhibitory enzymů farmakologie   MeSH
• koronavirová RNA-replikasa antagonisté a inhibitory   MeSH
• lidé MeSH
• mikrobiální testy citlivosti MeSH
• pyridony farmakologie   MeSH
• replikace viru účinky léků   MeSH
• SARS-CoV-2 účinky léků   enzymologie   fyziologie   MeSH
• viabilita buněk účinky léků   MeSH
• vztah mezi dávkou a účinkem léčiva MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• adenosinmonofosfát MeSH
• alanin MeSH
• antivirové látky MeSH
• benzothiazoly MeSH
• HeE1-2Tyr MeSH Prohlížeč
• inhibitory enzymů MeSH
• koronavirová RNA-replikasa MeSH
• NSP12 protein, SARS-CoV-2 MeSH Prohlížeč
• pyridony MeSH
• remdesivir MeSH Prohlížeč

Spanish flu, polio epidemics, and the ongoing COVID-19 pandemic are the most profound examples of severe widespread diseases caused by RNA viruses. The coronavirus pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demands affordable and reliable assays for testing antivirals. To test inhibitors of viral proteases, we have developed an inexpensive high-throughput assay based on fluorescent energy transfer (FRET). We assayed an array of inhibitors for papain-like protease from SARS-CoV-2 and validated it on protease from the tick-borne encephalitis virus to emphasize its versatility. The reaction progress is monitored as loss of FRET signal of the substrate. This robust and reproducible assay can be used for testing the inhibitors in 96- or 384-well plates.

• Klíčová slova
• SARS-CoV-2, TBEV, discovery, drug, flavivirus, high-throughput screening, papain-like, protease, virus,
• MeSH
• antivirové látky farmakologie   MeSH
• farmakoterapie COVID-19 MeSH
• fluorescenční barviva chemie   MeSH
• inhibitory proteas farmakologie   MeSH
• koronavirové proteasy podobné papainu antagonisté a inhibitory   chemie   genetika   metabolismus   MeSH
• lidé MeSH
• preklinické hodnocení léčiv MeSH
• rezonanční přenos fluorescenční energie metody   MeSH
• RNA-helikasy antagonisté a inhibitory   chemie   genetika   metabolismus   MeSH
• RNA-viry enzymologie   MeSH
• rychlé screeningové testy metody   MeSH
• SARS-CoV-2 enzymologie   MeSH
• serinové endopeptidasy chemie   genetika   metabolismus   MeSH
• virové nestrukturální proteiny antagonisté a inhibitory   chemie   genetika   metabolismus   MeSH
• viry klíšťové encefalitidy enzymologie   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• antivirové látky MeSH
• fluorescenční barviva MeSH
• inhibitory proteas MeSH
• koronavirové proteasy podobné papainu MeSH
• NS3 protein, flavivirus MeSH Prohlížeč
• papain-like protease, SARS-CoV-2 MeSH Prohlížeč
• RNA-helikasy MeSH
• serinové endopeptidasy MeSH
• virové nestrukturální proteiny MeSH